Noom's Refund Process Draws User Complaints
User frustration with the refund and cancellation process for the diet app Noom has become a topic of discussion in consumer forums. Users have cited unexpected charges and unclear cancellation pathways as sources of negative sentiment. The issue serves as a cautionary example that a frictionless exit experience is crucial for maintaining user trust and brand reputation in the digital health market.
- In 2022, Noom agreed to a $62 million settlement to resolve a class-action lawsuit alleging the company used a "deceptive and illegal" automatic renewal scheme. The settlement included $56 million in cash and $6 million in subscription credits for users who were enrolled in auto-renewing subscriptions between May 2016 and October 2020. - The lawsuit accused Noom of luring customers with "risk-free" trials, only to charge them non-refundable, lump-sum fees as high as $199 for multi-month memberships without clear consent. The cancellation process was also cited as being intentionally difficult, sometimes requiring users to cancel through a virtual coach who would not respond in time. - A key part of Noom's growth strategy was its pivot to a direct-to-consumer model, targeting former WeightWatchers users with a mobile-first, psychology-based program. This was fueled by aggressive ad spending and a robust affiliate marketing program that offered influencers up to $15 in commission for each new trial sign-up. - While many consumer wellness apps fall outside of HIPAA's direct oversight, Noom is HIPAA compliant and will sign a Business Associate Agreement (BAA). However, its terms of use clarify that its coaches are not licensed medical professionals and the app does not establish a physician-patient relationship, a crucial distinction for founders navigating health data privacy. - To improve user engagement and personalization, Noom has been integrating more AI-powered features, including AI-driven food logging via photo, text, or voice, and an AI personal health assistant named Welli. More recently, it launched features like an "AI Body Scan" and "Face Scan" to provide users with estimates of their biological age and other health indicators. - Noom's platform can sync with wearable devices and other health apps, including Apple HealthKit and Fitbit, to read and write data such as active calories, steps, and weight. However, users have reported persistent issues with syncing third-party device data, a common technical challenge for health apps that rely on API integrations. - In response to the rise of GLP-1 medications, Noom has expanded its services to include Noom Med, offering access to drugs like Ozempic and Wegovy. It has also launched programs for compounded GLP-1s and a "microdose" plan to make these medications more accessible and affordable, pairing them with its existing behavior change curriculum. - Despite its growth, the company faces significant challenges with user retention and the high cost of its human coaching model. High user churn after the initial subscription period negatively impacts lifetime value (LTV), a critical metric for any subscription-based consumer health startup.
